{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:04:26Z","timestamp":1793804666717,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T00:00:00Z","timestamp":1627689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00198-021-06078-z","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T04:14:59Z","timestamp":1627704899000},"page":"2449-2459","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4641-0051","authenticated-orcid":false,"given":"L.","family":"dos Santos Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2258-8071","authenticated-orcid":false,"given":"L. G.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-7435","authenticated-orcid":false,"given":"C. B.","family":"Calderipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-5965","authenticated-orcid":false,"given":"M. D.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-936X","authenticated-orcid":false,"given":"L. F.","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6560-9536","authenticated-orcid":false,"given":"A. C. U.","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,31]]},"reference":[{"key":"6078_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaws\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"6078_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","volume":"20","author":"AA Khan","year":"2017","unstructured":"Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A (2017) Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ. J Clin Densitom 20:8\u201324. https:\/\/doi.org\/10.1016\/j.jocd.2016.09.005","journal-title":"J Clin Densitom"},{"key":"6078_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jncimonographs\/lgz009","volume":"1","author":"CA Migliorati","year":"2019","unstructured":"Migliorati CA, Brennan MT, Peterson DE (2019) Medication-related osteonecrosis of the jaws. J Natl Cancer Inst Monogr 1:53. https:\/\/doi.org\/10.1093\/jncimonographs\/lgz009","journal-title":"J Natl Cancer Inst Monogr"},{"key":"6078_CR4","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00520-010-0882-1","volume":"18\u20138","author":"CA Migliorati","year":"2010","unstructured":"Migliorati CA, Woo SB, Hewson I, Barasch A, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer 18\u20138:1099\u20131106. https:\/\/doi.org\/10.1007\/s00520-010-0882-1","journal-title":"Support Care Cancer"},{"key":"6078_CR5","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1007\/s00784-018-2743-0","volume":"23\u20138","author":"SI Yamada","year":"2019","unstructured":"Yamada SI, Kurita H, Kondo E, Suzuki S, Nishimaki F, Yoshimura N, Morioka M, Ishii S, Kamata T (2019) Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review. Clin Oral Investig 23\u20138:3203\u20133211. https:\/\/doi.org\/10.1007\/s00784-018-2743-0","journal-title":"Clin Oral Investig"},{"key":"6078_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.11138\/ccmbm\/2017.14.1.173","volume":"14","author":"R Eastell","year":"2017","unstructured":"Eastell R, Walsh JS (2017) Anabolic treatment for osteoporosis: teriparatide. Clin Cases Miner Bone Metab 14:173\u2013178. https:\/\/doi.org\/10.11138\/ccmbm\/2017.14.1.173","journal-title":"Clin Cases Miner Bone Metab"},{"key":"6078_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-med-052218-020620","volume":"71","author":"C Cheng","year":"2019","unstructured":"Cheng C, Wentworth K, Shoback DM (2019) New frontiers in osteoporosis therapy. Annu Rev Med 71:277\u2013288. https:\/\/doi.org\/10.1146\/annurev-med-052218-020620","journal-title":"Annu Rev Med"},{"issue":"38","key":"6078_CR8","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1200\/JCO.19.02192","volume":"10","author":"IW Sim","year":"2020","unstructured":"Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Hjelle CP, Siddique M et al (2020) Teriparatide promotes bone healing in medication-related osteonecrosis of the jaw: a placebo-controlled, randomized trial. J Clin Oncol 10(38):2971\u20132980. https:\/\/doi.org\/10.1200\/JCO.19.02192","journal-title":"J Clin Oncol"},{"key":"6078_CR9","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow CD et al (2020). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. MetaArXiv. https:\/\/doi.org\/10.31222\/osf.io\/v7gm2","DOI":"10.31222\/osf.io\/v7gm2"},{"key":"6078_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7453\/gahmj.2013.008","volume":"2","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, CARE Group (2013) The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med 2:38\u201343. https:\/\/doi.org\/10.7453\/gahmj.2013.008","journal-title":"Glob Adv Health Med"},{"key":"6078_CR11","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 366. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"6078_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00198-019-05199-w","volume":"31","author":"Y Ohbayashi","year":"2020","unstructured":"Ohbayashi Y, Iwasaki A, Nakai F, Mashiba T, Miyake M (2020) A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration. Osteoporos Int 31:577\u2013585. https:\/\/doi.org\/10.1007\/s00198-019-05199-w","journal-title":"Osteoporos Int"},{"issue":"5","key":"6078_CR13","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00784-016-1973-2","volume":"21","author":"SO Hong","year":"2017","unstructured":"Hong SO, Lee CY, Jung J, Kim DY, Walter C, Kwon YD (2017) A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians. Clin Oral Investig 21(5):1905\u20131911. https:\/\/doi.org\/10.1007\/s00784-016-1973-2","journal-title":"Clin Oral Investig"},{"key":"6078_CR14","doi-asserted-by":"publisher","unstructured":"Petrovic M, Jelovac DB, Antic S, Antunovic M, Lukic N, Sabani M et al (2019) Medication-related osteonecrosis of the jaws: two center retrospective cohort studies. BioMed Res Int 8345309. https:\/\/doi.org\/10.1155\/2019\/8345309","DOI":"10.1155\/2019\/8345309"},{"key":"6078_CR15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.jcms.2017.07.014","volume":"45","author":"AS Martins","year":"2017","unstructured":"Martins AS, Correia JA, Salvado F, Caldas C, Santos N, Capelo A, Palmela P (2017) Relevant factors for treatment outcome and time to healing in medication-related osteonecrosis of the jaws - a retrospective cohort study. J Craniomaxillofac Surg 45:1736\u20131742. https:\/\/doi.org\/10.1016\/j.jcms.2017.07.014","journal-title":"J Craniomaxillofac Surg"},{"key":"6078_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan K, McGowan T, Ivanovski S (2018) Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 24:527\u2013536. https:\/\/doi.org\/10.1111\/odi.12708","journal-title":"Oral Dis"},{"key":"6078_CR17","unstructured":"Kanis JA (2007) Assessment of osteoporosis at the primary health\u2010care level. Technical Report, World Health Organization Collaborating Centre for Metabolic Bone Diseases, 66."},{"key":"6078_CR18","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41415-020-1642-3","volume":"228","author":"N Kanwar","year":"2020","unstructured":"Kanwar N, Bakr MM, Meer M, Siddiqi A (2020) Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature. Br Dent J 228:886\u2013892. https:\/\/doi.org\/10.1038\/s41415-020-1642-3","journal-title":"Br Dent J"},{"key":"6078_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","volume":"67","author":"R Kunchur","year":"2009","unstructured":"Kunchur R, Need A, Hughes T (2009) Clinical investigation of C terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 67:1167\u20131173","journal-title":"J Oral Maxillofac Surg"},{"key":"6078_CR20","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922\u2013932. https:\/\/doi.org\/10.1111\/jcpe.12455","journal-title":"J Clin Periodontol"},{"key":"6078_CR21","unstructured":"Vall H, Parmar M (2020) Teriparatide. StatPearls [Internet] Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559248\/. Accessed 10 Jan\u00a02021."},{"key":"6078_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/dj4040041","volume":"4","author":"YD Kwon","year":"2016","unstructured":"Kwon YD, Kim DY (2016) Role of teriparatide in medication-related osteonecrosis of the jaws (MRONJ). Dent J 4:41. https:\/\/doi.org\/10.3390\/dj4040041","journal-title":"Dent J"},{"issue":"9999","key":"6078_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","volume":"386","author":"BZ Leder","year":"2015","unstructured":"Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA (2015) Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet 19 386(9999):1147\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61120-5","journal-title":"Lancet 19"},{"key":"6078_CR24","unstructured":"FDA. (2009) Teriparatide. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021318s012lbl.pdf\/  . Accessed 25 Apr\u00a02021."},{"key":"6078_CR25","unstructured":"OCEBM Levels of Evidence Working Group*. \u201cThe Oxford levels of evidence 2\u201d. Oxford Centre for Evidence-Based Medicine. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence Accessed 25 Apr\u00a02021."}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06078-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T18:03:00Z","timestamp":1637604180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06078-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,31]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6078"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06078-z","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,31]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}